Literature DB >> 30172236

Integrated LAMP and immunoassay platform for diarrheal disease detection.

Christopher R Phaneuf1, Betty Mangadu1, Huu M Tran1, Yooli K Light2, Anchal Sinha1, Frank W Charbonier1, Tyler P Eckles1, Anup K Singh1, Chung-Yan Koh3.   

Abstract

The challenges of diagnosing infectious disease, especially in the developing world, and the shortcomings of available instrumentation have exposed the need for portable, easy-to-use diagnostic tools capable of detecting the wide range of causative microbes while operating in low resource settings. We present a centrifugal microfluidic platform that combines ultrasensitive immunoassay and isothermal amplification-based screening for the orthogonal detection of both protein and nucleic acid targets at the point-of-care. A disposable disc with automatic aliquoting inlets is paired with a non-contact heating system and precise rotary control system to yield an easy-to-use, field-deployable platform with versatile screening capabilities. The detection of three enterotoxins (cholera toxin, Staphylococcal enterotoxin B, and Shiga-like toxin 1) and three enteric bacteria (C. jejuni, E. coli, and S. typhimurium) were performed independently and shown to be highly sensitive (limit of detection = 1.35-5.50 ng/mL for immunoassays and 1-30 cells for isothermal amplification), highly exclusive in the presence of non-specific targets, and capable of handling a complex sample matrix like stool. The full panel of toxins and bacteria were reliably detected simultaneously on a single disc at clinically relevant sample concentrations in less than an hour. The ability of our technology to detect multiple analyte types in parallel at the point-of-care can serve a variety of needs, from routine patient care to outbreak triage, in a variety of settings to reduce disease impact and expedite effective treatment.
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Centrifugal; Enteric pathogens; Immunoassay; Isothermal amplification; LAMP; Microfluidics; Point-of-care

Mesh:

Substances:

Year:  2018        PMID: 30172236      PMCID: PMC6145809          DOI: 10.1016/j.bios.2018.08.005

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  48 in total

1.  Whole blood immunoassay based on centrifugal bead sedimentation.

Authors:  Ulrich Y Schaff; Greg J Sommer
Journal:  Clin Chem       Date:  2011-03-17       Impact factor: 8.327

Review 2.  Syndromic Panel-Based Testing in Clinical Microbiology.

Authors:  Poornima Ramanan; Alexandra L Bryson; Matthew J Binnicker; Bobbi S Pritt; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

3.  Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties.

Authors:  J Tuttle; T Gomez; M P Doyle; J G Wells; T Zhao; R V Tauxe; P M Griffin
Journal:  Epidemiol Infect       Date:  1999-04       Impact factor: 2.451

4.  Quenching of Unincorporated Amplification Signal Reporters in Reverse-Transcription Loop-Mediated Isothermal Amplification Enabling Bright, Single-Step, Closed-Tube, and Multiplexed Detection of RNA Viruses.

Authors:  Cameron S Ball; Yooli K Light; Chung-Yan Koh; Sarah S Wheeler; Lark L Coffey; Robert J Meagher
Journal:  Anal Chem       Date:  2016-03-24       Impact factor: 6.986

Review 5.  Existing and Emerging Technologies for Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2014-08

6.  Development of a Simple, Peripheral-Blood-Based Lateral-Flow Dipstick Assay for Accurate Detection of Patients with Enteric Fever.

Authors:  Iqbal Hassan Khan; M Abu Sayeed; Nishat Sultana; Kamrul Islam; Jakia Amin; M Omar Faruk; Umama Khan; Farhana Khanam; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

7.  Global, regional, and national causes of child mortality in 2008: a systematic analysis.

Authors:  Robert E Black; Simon Cousens; Hope L Johnson; Joy E Lawn; Igor Rudan; Diego G Bassani; Prabhat Jha; Harry Campbell; Christa Fischer Walker; Richard Cibulskis; Thomas Eisele; Li Liu; Colin Mathers
Journal:  Lancet       Date:  2010-05-11       Impact factor: 79.321

8.  Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard.

Authors:  Anne-Laure Page; Kathryn P Alberti; Vital Mondonge; Jean Rauzier; Marie-Laure Quilici; Philippe J Guerin
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

9.  Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture.

Authors:  Lameck N Ontweka; Lul O Deng; Jean Rauzier; Amanda K Debes; Fisseha Tadesse; Lucy A Parker; Joseph F Wamala; Bior K Bior; Michael Lasuba; Abiem Bona But; Francesco Grandesso; Christine Jamet; Sandra Cohuet; Iza Ciglenecki; Micaela Serafini; David A Sack; Marie-Laure Quilici; Andrew S Azman; Francisco J Luquero; Anne-Laure Page
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

10.  A rapid, low-cost, and microfluidic chip-based system for parallel identification of multiple pathogens related to clinical pneumonia.

Authors:  Guoliang Huang; Qin Huang; Lan Xie; Guangxin Xiang; Lei Wang; Hui Xu; Li Ma; Xianbo Luo; Juan Xin; Xinying Zhou; Xiangyu Jin; Lei Zhang
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

View more
  2 in total

1.  Healthy humans can be a source of antibodies countering COVID-19.

Authors:  Nileena Velappan; Hau B Nguyen; Sofiya Micheva-Viteva; Daniel Bedinger; Chunyan Ye; Betty Mangadu; Austin J Watts; Robert Meagher; Steven Bradfute; Bin Hu; Geoffrey S Waldo; Antonietta M Lillo
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  Application of Microfluidics in Immunoassay: Recent Advancements.

Authors:  Yuxing Shi; Peng Ye; Kuojun Yang; Jie Meng; Jiuchuan Guo; Zhixiang Pan; Qiaoge Bayin; Wenhao Zhao
Journal:  J Healthc Eng       Date:  2021-07-15       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.